A recent meta-analysis of CKD in patients who were not undergoing treatment with HD also indicates the efficacy of paricalcitol in lowering PTH levels, but with reference to a careful use of vitamin D analogues because of hypercalcemia and calcification risks [26]. This evidence concerns the gene PTH and chronic kidney disease.